The Galectin Therapeutics GT brand, founded in 2013 (United States), from 2 sister brands and 2214 competing brands. The Galectin Therapeutics GT brand is owned by Galectin Therapeutics, a company listed in New York. The sector of Galectin Therapeutics GT is Biotechnology.
Investment simulator :
Portfolio valuation
Galectin Therapeutics
(Galectin Therapeutics GT)
over 5 years*
USD 2.74